Multiple CAR-T cell therapy for acute B-cell lymphoblastic leukemia after hematopoietic stem cell transplantation: A case report

B-cell acute lymphoblastic leukemia (B-ALL) is the most common childhood malignancy. The cure rate has reached 90% after conventional chemotherapy and hematopoietic stem cell transplantation (HSCT), but the prognosis of patients with relapsed and refractory (R/R) leukemia is still poor after convent...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Lei, Xiaolin, Yu, Wu, Qian, Song, Xiaochen, Li, Wenjun, Hou, Yixi, Liu, Yue, Wang, Jing, Tian, Jun, Zuo, Xiaona, Zhou, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713842/
https://www.ncbi.nlm.nih.gov/pubmed/36466893
http://dx.doi.org/10.3389/fimmu.2022.1039929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713842/
https://www.ncbi.nlm.nih.gov/pubmed/36466893
http://dx.doi.org/10.3389/fimmu.2022.1039929

Ejemplares similares